Dr. Cephas Swamidoss is a board certified anesthesiologist who joined HSS in 2007. Prior to joining, he served as a staff obstetrical anesthesiologist and Residency Director for the Anesthesia Training Program at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He has an active interest in educational programs, clinical outcomes research as well as overseas medical missions.
Regional anesthesia
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Attending Anesthesiologist, Hospital for Special Surgery
Clinical Associate Professor of Anesthesiology, Weill Cornell Medical College
American Society of Anesthesiologists
New York State Society of Anesthesiologists
National Board of Medical Examiners, 1991
American Board of Anesthesiology, 1996, re-certified, 2004
Tufts University, BS Biology, 1986
Georgetown University, MS Biostatistics, 1987
Mount Sinai School of Medicine, MD, 1991
Columbia University, MPH, 2002
Yale New Haven Hospital
English
For all publications, please see the PubMed listing.
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of May 11, 2024, Dr. Swamidoss reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.
